{
    "Trade/Device Name(s)": [
        "Maximed Exichek TD 4224 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Exir Pharmaceutical Company",
    "510(k) Number": "K070239",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063212"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "May 14, 2007",
    "Summary Letter Received Date": "May 18, 2007",
    "Submission Date": "January 18, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Maximed Exichek TD 4224 meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Dry reagent biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for Maximed Exichek TD 4224 blood glucose monitoring system for quantitative measurement of glucose in capillary whole blood using electrochemical method.",
    "Indications for Use Summary": "Indicated for quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites for self-testing by persons with diabetes at home or healthcare professionals in clinical settings; not for neonatal or diabetes diagnosis/screening.",
    "fda_folder": "Clinical Chemistry"
}